How I’d invest $50,000 in growth stocks today

Investing for growth is the best and most exciting way to try to beat the market.

Growth could be hard to come by over the next few years so investors will have to choose their investments carefully.

If I were lucky enough to suddenly be given $50,000, here is how I’d invest it today:

BWX Ltd (ASX: BWX) is the owner of natural beauty brand Sukin. It has impressive growth plans to expand in several other countries such as the UK and Canada. It’s achieving fast results and I’d invest $5,000 into this business.

Challenger Ltd (ASX: CGF) is the market-leading annuity provider offering retirees a secure source of income for their hard-earned capital. The number of retirees reaching 65 years old is expected to dramatically increase over the next two decades which is why I’d be comfortable investing $10,000.

Collins Foods Ltd (ASX: CKF) is a franchisee operator of a large number of KFCs in Australia. It’s also just starting to expand into the Netherlands and Germany, which could make this investment a real zinger. I’d want to invest $5,000 into Collins Foods.

Freelancer Ltd (ASX: FLN) is the owner of one of the most popular freelancer websites in the world. The growth of the internet should give this company real long-term potential, I’d be willing to invest $5,000 into this more speculative option.

MFF Capital Investments Limited (ASX: MFF) is a listed investment company (LIC) that focuses on overseas options, giving huge scope for investment possibilities. It has outperformed most peers by a big margin over the last five years, which is why I’d be comfortable to invest $5,000 into this LIC.

NIB Holdings Limited (ASX: NHF) is the best performing private health insurer to own in my opinion. It’s been achieving great growth of policyholders year after year, which could make an investment of $5,000 very worthwhile over the long-term.

National Veterinary Care Ltd (ASX: NVL) is rapidly expanding its network of veterinary businesses in Australia and New Zealand by acquisition. It could be the perfect time to take advantage of the price weakness and make a $10,000 investment, with management expecting to pay dividends at the next report.

Ramsay Health Care Limited (ASX: RHC) is one of the biggest private hospital operators in the world. The long-term potential of Ramsay is substantial, thanks to the ageing demographics and construction plans it has. I’d be very happy to make a $5,000 investment in Ramsay shares.

Foolish takeaway

The above companies would create a nice, diversified portfolio of good growth options. If you only had to pick one or two options, I think National Vet Care and Ramsay will probably generate the best returns over the next two to three years

If you want even more growth options, you should read this.

Top 3 ASX Blue Chips To Buy In 2017

For many, blue chip stocks means stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool's in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool's Top 3 Blue Chip Stocks for 2017."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

If you're expecting to see the likes of Commonwealth Bank, Telstra and Wesfarmers shares on this list, you'll be sorely disappointed. Not only are their dividends growing at a snail's pace, their profits are under pressure too due to the increasing competitive environment.

The contrast to these "new breed" blue chips couldn't be greater... especially the very real prospect of significant share price gains, something that's looking less likely from the usual blue chip suspects.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand - and how quickly the share prices of these companies moves - we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor Tristan Harrison owns shares of Challenger Limited, NATVETCARE FPO, and Ramsay Health Care Limited. The Motley Fool Australia owns shares of BWX Limited and Challenger Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

HOT OFF THE PRESSES: My #1 Dividend Pick for 2017!

With its shares up 155% in just the last five years, this ‘under the radar’ consumer favourite is both a hot growth stock AND our expert’s #1 dividend pick for 2017. Now we’re pulling back the curtain for you... And all you have to do to discover the name, code and a full analysis is enter your email below!

Simply enter your email now to receive your copy of our brand-new FREE report, “The Motley Fool’s Top Dividend Stock for 2017.”

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.